San Diego Unified families, secure your child's school spot through the Choice program by November 3 for the best chance at ...
The Priority Review program is a new initiative launched by the current administration. It was first announced in June of ...
The U.S. Food and Drug Administration on Thursday announced the names of nine products, under a new fast-track review process ...
A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...
The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, ...
The Commissioner’s National Priority Voucher awards companies that align with specific national priorities—such as boosting ...
Medpage Today on MSN
FDA Doles Out First Nine Vouchers for Priority Drug Review
The FDA named the first nine products to undergo a new expedited review process that takes 1 to 2 months, the agency ...
Achieve Life Sciences (ACHV) and Disc Medicine (IRON) stocks rally after getting selected among winners of initial FDA ...
Shares of Disc Medicine jumped after the company said it received a Commissioner's National Priority Voucher from the Food and Drug Administration for its drug bitopertin. The stock climbed 27% to $94 ...
The government shutdown is now the third-longest funding lapse in modern history, and the Senate won't meet until Monday.
Disc is seeking accelerated approval of bitopertin for patients aged 12 years and older with EPPThe CNPV program is designed to reduce the drug application review process to 1-2 months WATERTOWN, Mass ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback